Stem cell models of Alzheimer’s disease: progress and challenges

Abstract A major challenge to our understanding of the molecular mechanisms of Alzheimer’s disease (AD) has been the lack of physiologically relevant in vitro models which capture the precise patient genome, in the cell type of interest, with physiological expression levels of the gene(s) of interes...

Full description

Bibliographic Details
Main Authors: Charles Arber, Christopher Lovejoy, Selina Wray
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Alzheimer’s Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13195-017-0268-4
id doaj-d1d7dc0400d54b04a411337757850849
record_format Article
spelling doaj-d1d7dc0400d54b04a4113377578508492020-11-25T00:46:08ZengBMCAlzheimer’s Research & Therapy1758-91932017-06-019111710.1186/s13195-017-0268-4Stem cell models of Alzheimer’s disease: progress and challengesCharles Arber0Christopher Lovejoy1Selina Wray2Department of Molecular Neuroscience, UCL Institute of NeurologyDepartment of Molecular Neuroscience, UCL Institute of NeurologyDepartment of Molecular Neuroscience, UCL Institute of NeurologyAbstract A major challenge to our understanding of the molecular mechanisms of Alzheimer’s disease (AD) has been the lack of physiologically relevant in vitro models which capture the precise patient genome, in the cell type of interest, with physiological expression levels of the gene(s) of interest. Induced pluripotent stem cell (iPSC) technology, together with advances in 2D and 3D neuronal differentiation, offers a unique opportunity to overcome this challenge and generate a limitless supply of human neurons for in vitro studies. iPSC-neuron models have been widely employed to model AD and we discuss in this review the progress that has been made to date using patient-derived neurons to recapitulate key aspects of AD pathology and how these models have contributed to a deeper understanding of AD molecular mechanisms, as well as addressing the key challenges posed by using this technology and what progress is being made to overcome these. Finally, we highlight future directions for the use of iPSC-neurons in AD research and highlight the potential value of this technology to neurodegenerative research in the coming years.http://link.springer.com/article/10.1186/s13195-017-0268-4Alzheimer’s diseaseInduced pluripotent stem cellsNeuronal differentiation3D cerebral organoids
collection DOAJ
language English
format Article
sources DOAJ
author Charles Arber
Christopher Lovejoy
Selina Wray
spellingShingle Charles Arber
Christopher Lovejoy
Selina Wray
Stem cell models of Alzheimer’s disease: progress and challenges
Alzheimer’s Research & Therapy
Alzheimer’s disease
Induced pluripotent stem cells
Neuronal differentiation
3D cerebral organoids
author_facet Charles Arber
Christopher Lovejoy
Selina Wray
author_sort Charles Arber
title Stem cell models of Alzheimer’s disease: progress and challenges
title_short Stem cell models of Alzheimer’s disease: progress and challenges
title_full Stem cell models of Alzheimer’s disease: progress and challenges
title_fullStr Stem cell models of Alzheimer’s disease: progress and challenges
title_full_unstemmed Stem cell models of Alzheimer’s disease: progress and challenges
title_sort stem cell models of alzheimer’s disease: progress and challenges
publisher BMC
series Alzheimer’s Research & Therapy
issn 1758-9193
publishDate 2017-06-01
description Abstract A major challenge to our understanding of the molecular mechanisms of Alzheimer’s disease (AD) has been the lack of physiologically relevant in vitro models which capture the precise patient genome, in the cell type of interest, with physiological expression levels of the gene(s) of interest. Induced pluripotent stem cell (iPSC) technology, together with advances in 2D and 3D neuronal differentiation, offers a unique opportunity to overcome this challenge and generate a limitless supply of human neurons for in vitro studies. iPSC-neuron models have been widely employed to model AD and we discuss in this review the progress that has been made to date using patient-derived neurons to recapitulate key aspects of AD pathology and how these models have contributed to a deeper understanding of AD molecular mechanisms, as well as addressing the key challenges posed by using this technology and what progress is being made to overcome these. Finally, we highlight future directions for the use of iPSC-neurons in AD research and highlight the potential value of this technology to neurodegenerative research in the coming years.
topic Alzheimer’s disease
Induced pluripotent stem cells
Neuronal differentiation
3D cerebral organoids
url http://link.springer.com/article/10.1186/s13195-017-0268-4
work_keys_str_mv AT charlesarber stemcellmodelsofalzheimersdiseaseprogressandchallenges
AT christopherlovejoy stemcellmodelsofalzheimersdiseaseprogressandchallenges
AT selinawray stemcellmodelsofalzheimersdiseaseprogressandchallenges
_version_ 1725266755007283200